Treatment of Herpes Simplex by Zinc Sulphate
Journal of Baghdad College of Dentistry
View Archive Info| Field | Value | |
| Title |
Treatment of Herpes Simplex by Zinc Sulphate
|
|
| Creator |
, Tagreed Altaei
|
|
| Description |
Background: Herpes simplex virus type 1 causes recurrent herpes labialis, a common disease afflicting up to 40% of adults worldwide. A randomized, double–blind trial was conducted to compare the effectiveness & the patient tolerance of topically applied 0.5% zinc sulphate suspension with those of a placebo in the treatment of herpes simplex lesion. Patients & Methods: Sixty patients were enrolled in this study. The effectiveness & symptomatic relief of pain were recorded and Fisher exact test were used. Results: The zinc sulphate group showed significantly complete healing (p=0.001) than the placebo group & pain free during the follow-up period. The zinc sulphate group showed significantly better than the placebo group during the follow-up period. The safety that has been recorded of the drug were satisfactory, there is no pain with zinc sulphate group, no side effects. Conclusion: Topically applied 0.5% zinc sulphate suspension is an effective drug for the treatment of herpes simplex lesion in a short period with pain less. |
|
| Publisher |
College of dentistry/ University of baghdad
|
|
| Date |
2017-01-30
|
|
| Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion Peer-reviewed Article |
|
| Identifier |
http://jbcd.uobaghdad.edu.iq/index.php/jbcd/article/view/1667
|
|
| Source |
Journal of Baghdad College of Dentistry; Vol 17 No 1 (2005); 54-56
2311-5270 1680-0087 |
|
| Language |
en
|
|
| Rights |
Copyright (c) 2017 Journal of Baghdad College of Dentistry
|
|